346 related articles for article (PubMed ID: 18336303)
41. Chemokine response induced by Chlamydia trachomatis in prostate derived CD45+ and CD45- cells.
Mackern Oberti JP; Breser ML; Nuñez N; Maccioni M; Rodríguez N; Wantia N; Ertl T; Miethke T; Rivero VE
Reproduction; 2011 Sep; 142(3):427-37. PubMed ID: 21730112
[TBL] [Abstract][Full Text] [Related]
42. Innate immunity: toll-like receptors and some more. A brief history, basic organization and relevance for the human newborn.
Fleer A; Krediet TG
Neonatology; 2007; 92(3):145-57. PubMed ID: 17476116
[TBL] [Abstract][Full Text] [Related]
43. Regulation of innate immune responses by Toll-like receptors.
Takeda K; Akira S
Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
[TBL] [Abstract][Full Text] [Related]
44. Sensing the enemy, containing the threat: cell-autonomous immunity to Chlamydia trachomatis.
Finethy R; Coers J
FEMS Microbiol Rev; 2016 Nov; 40(6):875-893. PubMed ID: 28201690
[TBL] [Abstract][Full Text] [Related]
45. [Responses with participation of toll-like receptors in protective immunity and in pathologic states].
Skivka LM; Pozur VV
Ukr Biokhim Zh (1999); 2008; 80(3):5-20. PubMed ID: 18959023
[TBL] [Abstract][Full Text] [Related]
46. Recognition of pathogenic microorganisms by Toll-like receptors.
Netea MG; Van der Meer JW; Kullberg BJ
Drugs Today (Barc); 2006 Mar; 42 Suppl A():99-105. PubMed ID: 16683049
[TBL] [Abstract][Full Text] [Related]
47. Evaluating the role of Toll-like receptors in diseases of the central nervous system.
Carty M; Bowie AG
Biochem Pharmacol; 2011 Apr; 81(7):825-37. PubMed ID: 21241665
[TBL] [Abstract][Full Text] [Related]
48. Duration of untreated chlamydial genital infection and factors associated with clearance: review of animal studies.
Miyairi I; Ramsey KH; Patton DL
J Infect Dis; 2010 Jun; 201 Suppl 2():S96-103. PubMed ID: 20470047
[TBL] [Abstract][Full Text] [Related]
49. Chlamydia heat shock protein 60 induces trophoblast apoptosis through TLR4.
Equils O; Lu D; Gatter M; Witkin SS; Bertolotto C; Arditi M; McGregor JA; Simmons CF; Hobel CJ
J Immunol; 2006 Jul; 177(2):1257-63. PubMed ID: 16818785
[TBL] [Abstract][Full Text] [Related]
50. The effect of doxycycline treatment on the development of protective immunity in a murine model of chlamydial genital infection.
Su H; Morrison R; Messer R; Whitmire W; Hughes S; Caldwell HD
J Infect Dis; 1999 Oct; 180(4):1252-8. PubMed ID: 10479155
[TBL] [Abstract][Full Text] [Related]
51. Toll-like receptors as adjuvant receptors.
Kaisho T; Akira S
Biochim Biophys Acta; 2002 Feb; 1589(1):1-13. PubMed ID: 11909637
[TBL] [Abstract][Full Text] [Related]
52. A mathematical model for the investigation of the Th1 immune response to Chlamydia trachomatis.
Wilson DP; Timms P; McElwain DL
Math Biosci; 2003 Mar; 182(1):27-44. PubMed ID: 12547038
[TBL] [Abstract][Full Text] [Related]
53. The role of NOD1 and NOD2 in host defense against chlamydial infection.
Zou Y; Lei W; He Z; Li Z
FEMS Microbiol Lett; 2016 Sep; 363(17):. PubMed ID: 27421958
[TBL] [Abstract][Full Text] [Related]
54. Chlamydial hsp60 and the immunopathogenesis of chlamydial disease.
Morrison RP
Semin Immunol; 1991 Jan; 3(1):25-33. PubMed ID: 1680011
[TBL] [Abstract][Full Text] [Related]
55. [Antiinfective host defense mechanism: toll-like receptors and innate immunity].
Takesue Y; Ohge H; Kohyama M; Imamura Y; Murakami Y; Sueda T
Nihon Geka Gakkai Zasshi; 2003 Jul; 104(7):494-8. PubMed ID: 12884772
[TBL] [Abstract][Full Text] [Related]
56. Chlamydia trachomatis: Protective Adaptive Responses and Prospects for a Vaccine.
Poston TB; Darville T
Curr Top Microbiol Immunol; 2018; 412():217-237. PubMed ID: 27033698
[TBL] [Abstract][Full Text] [Related]
57. [Evidence of antibodies against the chlamydial heat shock protein (cHSP60) in women from "in vitro" fertilization program].
Pospísil L; Canderle J; Stroblová H; Unzeitig V; Huser M
Ceska Gynekol; 2004 Jul; 69(4):253-7. PubMed ID: 15369241
[TBL] [Abstract][Full Text] [Related]
58. Lack of correlation between the detection of Chlamydia trachomatis DNA in synovial fluid from patients with a range of rheumatic diseases and the presence of an antichlamydial immune response.
Wilkinson NZ; Kingsley GH; Sieper J; Braun J; Ward ME
Arthritis Rheum; 1998 May; 41(5):845-54. PubMed ID: 9588736
[TBL] [Abstract][Full Text] [Related]
59. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation.
Sasu S; LaVerda D; Qureshi N; Golenbock DT; Beasley D
Circ Res; 2001 Aug; 89(3):244-50. PubMed ID: 11485974
[TBL] [Abstract][Full Text] [Related]
60. The STING pathway in response to chlamydial infection.
Wen Y; Li Z
Microb Pathog; 2020 Mar; 140():103950. PubMed ID: 31899324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
